Avience Biomedicals IPO Allotment Status: Check Online on Registrar & NSE SME

As on 22 June 2026, 05:00 PM IST, the allotment for the Avience Biomedicals IPO of ₹30.24 crores is expected to be finalized on 23 June 2026. Investors can check the allotment status through Skyline Financial Services Private Limited or on the NSE SME website using their PAN number or application number.

The subscription for the Avience Biomedicals IPO closed on 22 June 2026. The IPO was open for bidding from 18 June 2026 to 22 June 2026 and was priced in the range of ₹196 to ₹208 per share. The total issue size was ₹30.24.

Shares are expected to be credited to investors’ demat accounts on , while the IPO is scheduled to list on NSE SME on 25 June 2026.

How to check Avience Biomedicals IPO Allotment Status on Registrar site

Step 1: Visit Skyline Financial Services Private Limited
Step 2: Select AVIENCE from the drop-down menu on the page
Step 3: Enter details required like PAN Card, Application Number, or Demat Account Number
Step 4: Click on the ‘Submit’ Button and view your allotment status

How to check Avience Biomedicals IPO Allotment Status on NSE website

Step 1: Go to Status of Issue Application Page on NSE Website
Step 2: Select “Equity & SME IPO bid details”
Step 3: Select IPO Company Code AVIENCE from the Dropdown
Step 4: Enter your PAN & Application Number in the required field
Step 5: Click on “Submit” Button and view your allotment status

What happens if you get the Avience Biomedicals IPO allotment?

If you get Avience Biomedicals IPO allotment, the company’s shares will be credited to your demat account on [-], based on your allotment. Once the shares are credited, the amount blocked in your bank account will be debited accordingly.

After the IPO is listed on 25 June 2026 on the NSE SME, you may choose to either hold the shares as a long-term investment or sell them in the market.

What if you didn’t get the Avience Biomedicals IPO allotment?

If you didn’t receive allotment of Avience Biomedicals IPO:
• Refunds will be initiated on or about 24 June 2026.
• The amount will be credited to your bank account linked to UPI On the other hand, if allotted shares will reflect in your Demat by 24 June 2026
• After the listing date, you can continue to track and invest in the stock directly through Kotak Neo

About Avience Biomedicals

Avience Biomedicals, established in 2019 amidst the global challenges of the COVID-19 pandemic, has emerged as an innovative diagnostics solutions provider. Recognised as a startup and a small-scale industry under MSME, the company is committed to empowering healthcare professionals with advanced technology. Avience Biomedicals commenced its journey by producing essential diagnostic kits such as Viral Transport Media (VTM), COVID, Human Immunodeficiency Viruses (HIV), HBsAg, Malaria, Dengue, and others, aimed at aiding medical institutions with affordable and high-quality solutions. The company has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as serology products, biochemistry analysers, and biochemistry reagents, demonstrating a dedication to addressing diverse healthcare needs. Being purely focused on the B2B and B2G markets, their products cater to pathology labs, microbiology labs, hospitals, and research centres across India and internationally. In addition to manufacturing, the company also acts as a distributor and trader of medical equipment.